Premium
Onychopathy in a Patient with Fetal Hydantoin Syndrome
Author(s) -
Verdeguer Juan M.,
Ramon Dolores,
Moragon Manuel,
Betlloch Isabel,
Jorda Esperanza,
Planelles M.D Victoria
Publication year - 1988
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/j.1525-1470.1988.tb00885.x
Subject(s) - hydantoin , medicine , anticonvulsant , girl , fetus , drug , pregnancy , confusion , pediatrics , teratology , epilepsy , pharmacology , psychiatry , biochemistry , genetics , biology , psychology , psychoanalysis
Hydantoin is an anticonvulsant drug with several side effects. A teralogenic potential has been suggested. The fetal hydantoin syndrome is an entity that consists of a broad range of morphologic and developmental disorders in children born of epileptic mothers exposed to hydantoin during pregnancy. We treated a girl in whom onychopathy was a monosymptomatic or mild form of this syndrome.